Healthcare Industry News Weekly Wrap-Up: November 10, 2023
// Biotech and Pharma Therapeutics AstraZeneca Pays $185M to Add Oral GLP-1 Drug Candidate to Pipeline November 9, 2023 / AstraZeneca / GLP-1 / Metabolic Disorder The available metabolic disorder drugs targeting the GLP-1 receptor are all injectable products. The...
